# An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia

> **NCT01571596** · PHASE1,PHASE2 · COMPLETED · sponsor: **Kyowa Kirin Co., Ltd.** · enrollment: 23 (actual)

## Conditions studied

- X-linked Hypophosphatemia

## Interventions

- **DRUG:** KRN23

## Key facts

- **NCT ID:** NCT01571596
- **Lead sponsor:** Kyowa Kirin Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2013-09
- **Final completion:** 2014-06
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2024-06-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01571596

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01571596, "An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01571596. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*